Phibro Animal Health Corporation (PAHC) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello and thank you for standing by. My name is Regina and I will be your conference operator today. At this time, I would like to welcome everyone to the Fibro Animal Health Corporation second quarter 2026 conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during this time, simply press star then the number one on your telephone keypad. To withdraw your question, press star one again. I'd now like to turn the conference over to Glen David, Chief Financial Officer. Please go ahead. Thank you, Regina. Good day, and welcome to the Fibro Animal Health Corporation earnings call for our fiscal second quarter ending December 31st, 2025. My name is Glen David, and I am the Chief Financial Officer of Fibro Animal Health Corporation. I am joined on today's call by Jack Bentime, Fibro's Chairman. Donnie Van Thyme, Director and Executive Vice President of Corporate Strategy, and as recently announced, our CEO designate, and Larry Miller, Chief Operating Officer. Today, we will cover financial performance for our second quarter and provide updated financial guidance for our fiscal year ending June 30th, 2026. At the conclusion of our remarks, we will open the lines for your questions. I would like to remind you that we are providing a simultaneous webcast of this call on our website, pahc.com. Also, on the investor section of our website, you will find copies of the earnings press release and quarterly form 10-Q, as well as the transcripts and slides discussed and presented on this call. Our remarks today will include forward-looking statements, and actual results could differ materially from those projections. For a list and description...